During the recent session, NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s traded shares were 106.99 million, with the beta value of the company hitting -0.58. At the last check today, the stock’s price was $0.26, reflecting an intraday gain of 42.28% or $0.08. The 52-week high for the NLSP share is $1.53, that puts it down -488.46 from that peak though still a striking 57.69% gain since the share price plummeted to a 52-week low of $0.11. The company’s market capitalization is $11.27M, and the average trade volume was 6.79 million shares over the past three months.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
NLS Pharmaceutics Ltd (NLSP) registered a 42.28% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 42.28% in intraday trading to $0.26, hitting a weekly high. The stock’s 5-day price performance is 39.00%, and it has moved by 48.88% in 30 days. Based on these gigs, the overall price performance for the year is -73.75%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.15%.
NLSP Dividends
NLS Pharmaceutics Ltd is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
